1BRUNETTO MR,GIARIN M,SARACCO G,et al.Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B[J].Gastroenterology,1993,105:845-850. 被引量：1
2SEO Y,YOON S,HAMNO K,et al.Response to interferon-α in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay[J].J Clin Gastroenterol,2004,38(5):460-464. 被引量：1
3CARMAN WF,ACYNA MR,HADZIYANNIS S,et al.Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis infection[J].Lancet,1989,2:588-591. 被引量：1
5ZHANG X,HAN Y,LU Z,et al.Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B[J].J Gastroenterol Hepatol,2001,16(4):393-398. 被引量：1
6NAOUMOV NV,THOMAS MG,MASON AL,et al.Genomic variations in the hepatitis B core gene:a possible factor influencing response to interferon alpha treatment[J].Gastroenterology,1995,108:505-514. 被引量：1
7BERTOLETTI A,SETTE A,CHISARIF V,et al.Natural variants of cytotoxic epitopes are T-cell[J].Nature,1994,369:407-410. 被引量：1
8ETTIA B,CHISARI FV,PENNA A,et al.Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein[J].J Virol,1993,67:2376-2380. 被引量：1
9BOZKAYA H,AYOLA B,LOK ASF.High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection[J].Hepatology,1996,24:32-37. 被引量：1
10SHINDO M.Genomic variations in precore and cytotoxic T lymphocyte regions in chronic hepatitis B in relationship to interferon responsiveness[J].Liver,2000,20(2):136-142. 被引量：1
4Buti M, Cotrina M, Chan H, et al. Rapid method for the detection of anti-HCV antibodes in patients with chronic hepatitis C. Rev Esp Enferm Dig, 2000,92:140-146. 被引量：1
5Antonelli G, Currenti M, Turriziani O, et al. Relative frequency of nonneutralizing antibodies to interferon(IFN) in hepatitis patients treat ed with different IFN-α preparations. J Infect Dis, 1992, 165: 593-594. 被引量：1
6Roffi L, Mels GC, Antonelli GA, et al. Breakthrough during recombinant interferon Alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, Etiology and Management. Hepatology, 1995, 21 : 645-649. 被引量：1
7Los ASF, Lai CL, Leeung E KY, et al. Interferon antibodies may negate the antiviral effects of recombinant α-interferon. Hepatology,1990, 12: 1266-1270. 被引量：1
8Rossner MT. Hepatitis B virus X-gene product: A promiscuous trans critional activator. J Med Virol, 1992, 36:101-107. 被引量：1
9Sato S, Suzuki K, Akakane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med, 1995, 122:241-248. 被引量：1
7Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
